Home Applications 011283 Application 011283
Type NDA
Sponsor DELCOR ASSET CORP Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 003 KENACORT TRIAMCINOLONE TABLET;ORAL 1MG No No 006 KENACORT TRIAMCINOLONE TABLET;ORAL 4MG No No 008 KENACORT TRIAMCINOLONE TABLET;ORAL 2MG No No 010 KENACORT TRIAMCINOLONE TABLET;ORAL 8MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N011283-003 KENACORT TRIAMCINOLONE 1MG TABLET / ORAL Approved before 1982 N011283-006 KENACORT TRIAMCINOLONE 4MG TABLET / ORAL Approved before 1982 N011283-008 KENACORT TRIAMCINOLONE 2MG TABLET / ORAL Approved before 1982 N011283-010 KENACORT TRIAMCINOLONE 8MG TABLET / ORAL Approved before 1982
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 5 of 5 · 180 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N011283-003 KENACORT 1MG TABLET / ORAL Approved before 1982 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N011283-006 KENACORT 4MG TABLET / ORAL Approved before 1982 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N011283-008 KENACORT 2MG TABLET / ORAL Approved before 1982 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N011283-010 KENACORT 8MG TABLET / ORAL Approved before 1982 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N011283-003 KENACORT 1MG TABLET / ORAL Approved before 1982 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N011283-006 KENACORT 4MG TABLET / ORAL Approved before 1982 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N011283-008 KENACORT 2MG TABLET / ORAL Approved before 1982 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N011283-010 KENACORT 8MG TABLET / ORAL Approved before 1982 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N011283-003 KENACORT 1MG TABLET / ORAL Approved before 1982 e64feba35796…2022-09-29 23:25 UTC 2022-09 N011283-006 KENACORT 4MG TABLET / ORAL Approved before 1982 e64feba35796…2022-09-29 23:25 UTC 2022-09 N011283-008 KENACORT 2MG TABLET / ORAL Approved before 1982 e64feba35796…2022-09-29 23:25 UTC 2022-09 N011283-010 KENACORT 8MG TABLET / ORAL Approved before 1982 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N011283-003 KENACORT 1MG TABLET / ORAL Approved before 1982 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N011283-006 KENACORT 4MG TABLET / ORAL Approved before 1982 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N011283-008 KENACORT 2MG TABLET / ORAL Approved before 1982 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N011283-010 KENACORT 8MG TABLET / ORAL Approved before 1982 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N011283-003 KENACORT 1MG TABLET / ORAL Approved before 1982 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N011283-006 KENACORT 4MG TABLET / ORAL Approved before 1982 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N011283-008 KENACORT 2MG TABLET / ORAL Approved before 1982 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N011283-010 KENACORT 8MG TABLET / ORAL Approved before 1982 a50c72e98297…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.